This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fazioli, F
Right arrow Articles by Di Fiore, P P
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fazioli, F
Right arrow Articles by Di Fiore, P P

 Previous Article  |  Next Article 

Mol Cell Biol. 1991 April; 11(4): 2040-2048

The erbB-2 mitogenic signaling pathway: tyrosine phosphorylation of phospholipase C-gamma and GTPase-activating protein does not correlate with erbB-2 mitogenic potency.

F Fazioli, U H Kim, S G Rhee, C J Molloy, O Segatto and P P Di Fiore

Laboratory of Molecular and Cellular Biology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892.

ABSTRACT

The erbB-2 gene product, gp185erbB-2, unlike the structurally related epidermal growth factor (EGF) receptor (EGFR), exhibits constitutive kinase and transforming activity. We used a chimeric EGFR/erbB-2 expression vector to compare the mitogenic signaling pathway of the erbB-2 kinase with that of the EGFR, at similar levels of expression, in response to EGF stimulation. The EGFR/erbB-2 chimera was significantly more active in inducing DNA synthesis than the EGFR when either was expressed in NIH 3T3 cells. Analysis of biochemical pathways implicated in signal transduction by growth factor receptors indicated that both phospholipase C type gamma (PLC-gamma) and the p21ras GTPase-activating protein (GAP) are substrates for the erbB-2 kinase in NIH 3T3 fibroblasts. However, under conditions in which activation of the erbB-2 kinase induced DNA synthesis at least fivefold more efficiently than the EGFR, the levels of erbB-2- or EGFR-induced tyrosine phosphorylation of PLC-gamma and GAP were comparable. In addition, the stoichiometry of tyrosine phosphorylation of these putative substrates by erbB-2 appeared to be at least an order of magnitude lower than that induced by platelet-derived growth factor receptors at comparable levels of mitogenic potency. Thus, our results indicate that differences in tyrosine phosphorylation of PLC-gamma and GAP do not account for the differences in mitogenic activity of the erbB-2 kinase compared with either the EGFR or platelet-derived growth factor receptor in NIH 3T3 fibroblasts.

Mol Cell Biol. 1991 April; 11(4): 2040-2048




This article has been cited by other articles:

  • Tan, M., Li, P., Klos, K. S., Lu, J., Lan, K.-H., Nagata, Y., Fang, D., Jing, T., Yu, D. (2005). ErbB2 Promotes Src Synthesis and Stability: Novel Mechanisms of Src Activation That Confer Breast Cancer Metastasis. Cancer Res. 65: 1858-1867 [Abstract] [Full Text]  
  • Barbacci, E. G., Pustilnik, L. R., Rossi, A. M. K., Emerson, E., Miller, P. E., Boscoe, B. P., Cox, E. D., Iwata, K. K., Jani, J. P., Provoncha, K., Kath, J. C., Liu, Z., Moyer, J. D. (2003). The Biological and Biochemical Effects of CP-654577, a Selective erbB2 Kinase Inhibitor, on Human Breast Cancer Cells. Cancer Res. 63: 4450-4459 [Abstract] [Full Text]  
  • Hendriks, B. S., Opresko, L. K., Wiley, H. S., Lauffenburger, D. (2003). Coregulation of Epidermal Growth Factor Receptor/Human Epidermal Growth Factor Receptor 2 (HER2) Levels and Locations: Quantitative Analysis of HER2 Overexpression Effects. Cancer Res. 63: 1130-1137 [Abstract] [Full Text]  
  • Piccinini, G., Bacchiocchi, R., Serresi, M., Vivani, C., Rossetti, S., Gennaretti, C., Carbonari, D., Fazioli, F. (2002). A Ligand-inducible Epidermal Growth Factor Receptor/Anaplastic Lymphoma Kinase Chimera Promotes Mitogenesis and Transforming Properties in 3T3 Cells. J. Biol. Chem. 277: 22231-22239 [Abstract] [Full Text]  
  • Harris, L. N., Yang, L., Liotcheva, V., Pauli, S., Iglehart, J. D., Colvin, O. M., Hsieh, T. S. (2001). Induction of Topoisomerase II Activity after ErbB2 Activation Is Associated with a Differential Response to Breast Cancer Chemotherapy. Clin. Cancer Res. 7: 1497-1504 [Abstract] [Full Text]  
  • Dankort, D., Maslikowski, B., Warner, N., Kanno, N., Kim, H., Wang, Z., Moran, M. F., Oshima, R. G., Cardiff, R. D., Muller, W. J. (2001). Grb2 and Shc Adapter Proteins Play Distinct Roles in Neu (ErbB-2)-Induced Mammary Tumorigenesis: Implications for Human Breast Cancer. Mol. Cell. Biol. 21: 1540-1551 [Abstract] [Full Text]  
  • Fiorentino, L., Pertica, C., Fiorini, M., Talora, C., Crescenzi, M., Castellani, L., Alemà, S., Benedetti, P., Segatto, O. (2000). Inhibition of ErbB-2 Mitogenic and Transforming Activity by RALT, a Mitogen-Induced Signal Transducer Which Binds to the ErbB-2 Kinase Domain. Mol. Cell. Biol. 20: 7735-7750 [Abstract] [Full Text]  
  • Bell, C. A., Tynan, J. A., Hart, K. C., Meyer, A. N., Robertson, S. C., Donoghue, D. J. (2000). Rotational Coupling of the Transmembrane and Kinase Domains of the Neu Receptor Tyrosine Kinase. Mol. Biol. Cell 11: 3589-3599 [Abstract] [Full Text]  
  • Xu, J, Ziemnicka, D, Merz, G., Kotula, L (2000). Human spectrin Src homology 3 domain binding protein 1 regulates macropinocytosis in NIH 3T3 cells. J. Cell Sci. 113: 3805-3814 [Abstract]  
  • Zrihan-Licht, S., Lim, J., Keydar, I., Sliwkowski, M. X., Groopman, J. E., Avraham, H. (1997). Association of Csk-homologous Kinase (CHK) (formerly MATK) with HER-2/ErbB-2 in Breast Cancer Cells. J. Biol. Chem. 272: 1856-1863 [Abstract] [Full Text]  
  • Cohen, B. D., Kiener, P. A., Green, J. M., Foy, L., Fell, H. P., Zhang, K. (1996). The Relationship between Human Epidermal Growth-like Factor Receptor Expression and Cellular Transformation in NIH3T3 Cells. J. Biol. Chem. 271: 30897-30903 [Abstract] [Full Text]  
  • Cohen, B. D., Green, J. M., Foy, L., Fell, H. P. (1996). HER4-mediated Biological and Biochemical Properties in NIH 3T3 Cells. J. Biol. Chem. 271: 4813-4818 [Abstract] [Full Text]  
  • Baulida, J., Kraus, M. H., Alimandi, M., Di Fiore, P. P., Carpenter, G. (1996). All ErbB Receptors Other Than the Epidermal Growth Factor Receptor Are Endocytosis Impaired. J. Biol. Chem. 271: 5251-5257 [Abstract] [Full Text]  
  • Aaronson, S. (1991). Growth factors and cancer. Science 254: 1146-1153 [Abstract]  
  • Levkowitz, G., Oved, S., Klapper, L. N., Harari, D., Lavi, S., Sela, M., Yarden, Y. (2000). c-Cbl Is a Suppressor of the Neu Oncogene. J. Biol. Chem. 275: 35532-35539 [Abstract] [Full Text]  
  • Bougeret, C., Jiang, S., Keydar, I., Avraham, H. (2001). Functional Analysis of Csk and CHK Kinases in Breast Cancer Cells. J. Biol. Chem. 276: 33711-33720 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»